Proteomic analysis of the anti-cancer effect of 20S-ginsenoside Rg 3 in human colon cancer cell lines

Bioscience, Biotechnology and Biochemistry

Volumn 73, Issue 4, 2009, Pages 811-816

  Lee, Seo Young ^a   Kim, Geun Tae ^a   Roh, Si Hun ^a   Song, Jin Su ^a   Kim, Hie Joon ^a   Hong, Soon Sun ^b   Kwon, Sung Won ^a   Park, Jeong Hill ^a  

^a Seoul National University   (South Korea)

^b Inha University School of Medicine   (South Korea)

Author keywords

Anti cancer activity; Colon cancer; Ginsenoside; Proteomics

Indexed keywords

ANTI-CANCER ACTIVITY; ANTI-PROLIFERATIVE; ANTIPROLIFERATIVE EFFECT; APOPTOSIS; CASPASE-3; COLON CANCER; COLON CANCER CELLS; DNA REPLICATIONS; FLOW CYTOMETRY ANALYSIS; GINSENOSIDE; GLUTATHIONE-S-TRANSFERASE; GROWTH FACTOR; HERBAL MEDICINES; HUMAN COLON CANCER CELLS; MALDI-TOF/TOF MS; PHARMACOLOGICAL EFFECTS; PROTEIN LEVEL; PROTEOMIC ANALYSIS; PROTEOMICS; TWO-DIMENSIONAL GEL ELECTROPHORESIS;

CELL CULTURE; CELL DEATH; CHEMOTHERAPY; ELECTROPHORESIS; FLOW CYTOMETRY; GELATION; MOLECULAR BIOLOGY; NUCLEIC ACIDS; PROTEINS;

CYTOTOXICITY;

ANTINEOPLASTIC AGENT; GINSENOSIDE; GINSENOSIDE RG 3; PROTEIN;

ANIMAL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CHEMISTRY; COLON TUMOR; DRUG EFFECT; GENE EXPRESSION REGULATION; HUMAN; ISOLATION AND PURIFICATION; MASS SPECTROMETRY; METABOLISM; PATHOLOGY; PROTEOMICS; STEREOISOMERISM; TUMOR CELL LINE; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GINSENOSIDES; HUMANS; PROTEINS; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; STEREOISOMERISM;

PANAX GINSENG;

EID: 67249166275     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.80637     Document Type: Article

References (19)

1. Mochizuki M, Yoo YC, Matsuzawa K, Sato K, Saiki I, Tonooka S, Samukawa K, and Azuma I, Biol. Pharm. Bull., 18, 1197- 1202 (1995).
2. Iishi H, Tatsuta M, Baba M, Uehara H, Nakaizumi A, Shinkai K, Akedo H, Funai H, Ishiguro S, and Kitagawa I, Clin. Exp. Metastasis, 15, 603-611 (1997).
3. Keum YS, Seong SH, Chun KS, Park KK, Park JH, Lee SK, and Surh YJ, Mutat. Res., 75-85, 523-524 (2003).
4. Yue PYK, Wong DYL, Wu PK, Leung PY, Mak NK, Yeung HW, Liu L, Cai Z, Jiang ZH, Fan TPD, and Wong RNS, Biochem. Pharmacol., 72, 437-445 (2006).
5. Park IH, Piao LZ, Kwon SW, Lee YJ, Cho SY, Park MK, and Park JH, Chem. Pharm. Bull., 50, 538-540 (2002).
6. Liu WK, Xu SX, and Che CT, Life Sci., 67, 1297-1306 (2000).
7. Herr I and Debatin KM, Blood, 98, 2603-2614 (2001).
8. Zhang BL, Drug Resist. Updat., 9, 134-141 (2006).
9. Zhang BL, Zhang YQ, Dagher MC, and Shacter E, Cancer Res., 65, 6054-6062 (2005).
10. Raynal P and Pollard HB, Biochim. Biophys. Acta, 63-93, 1197 (1994).
11. Alfonso P, Nunez A, Madoz-Gurpide J, Lombardia L, Sanchez L, and Casal JI, Proteomics, 5, 2602-2611 (2005).
12. O'Neill GM, Stehn J, and Gunning PW, Semin. Cancer Biol. 18, 35-44 (2008).
13. Townsend DM and Tew KD, Oncogene, 22, 7369-7375 (2003).
14. Ebert MN, Beyer-Sehlmeyer G, Liegibel UM, Kautenburger T, Becker TW, and Pool-Zobel BL, Nutr. Cancer, 41, 156-164 (2001).
15. Royle SJ, Cell. Mol Life Sci., 63, 1823-1832 (2006).
16. Nicolas E, Ait-Si-Ali S, and Trouche D, Nucleic Acids Res., 29, 3131-3136 (2001).
17. Jonsson ZO and Hubscher U, Bioessays, 19, 967-975 (1997).
18. Lavezzi AM, Ottaviani G, De Ruberto F, Fichera G, and Matturri L, Anticancer Res., 22, 2077-2081 (2002).
19. Haider SK, Anumanthan G, Maddula R, Mann J, Chytil A, and Gonzalez AL, Cancer Res., 66, 6156-6166 (2006).